Article Details
Retrieved on: 2019-03-05 14:10:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Immunomic Therapeutics</b>' investigational UNITE platform uniquely combines their proprietary lysosomal targeting technology, optimal use of adjuvants ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here